covid-19

COVID-19 | Pharmacovigilance Update

COVID-19 | Pharmacovigilance Update

In response to the COVID-19 pandemic, the Food and Drug Administration (FDA), European Medicine Agency (EMA) and other national health authorities have published guidelines and recommendations regarding post-authorisation Adverse Event (AE) reporting during this...

COVID-19 | Conducting Remote Audits

COVID-19 | Conducting Remote Audits

Following the recent confirmation from Regulatory Authorities that GxP compliance should be maintained during the coronavirus outbreak, encouraging alternative approaches for routine regulatory oversight, remote auditing represents the viable alternative during these...

COVID-19 | Mitigation & Management

COVID-19 | Mitigation & Management

As COVID-19 Brings Global Uncertainty, Can We Maintain Certainty Regarding Our Regulatory Obligations? ADAMAS has brought together a range of specific remote service offerings which will not only ensure you can maintain compliance, but also have peace of mind that...

Archives